Showing results (1-10 of 594) with videos related to
Sort By:
Pageof 60
Statistical Methods in Medical Research|June 17, 2004
A perspective on surrogate endpoints in controlled clinical trialsGeert Molenberghs, Tomasz Burzykowski, Ariel Alonso, et al.Controlled Clinical Trials|December 31, 2002
Statistical challenges in the evaluation of surrogate endpoints in randomized trialsGeert Molenberghs, Marc Buyse, Helena Geys, et al.Biometrics|October 3, 2014
On the relationship between the causal-inference and meta-analytic paradigms for the validation of surrogate endpointsAriel Alonso, Wim Van der Elst, Geert Molenberghs, et al.Statistical Methods in Medical Research|July 18, 2009
A unified framework for the evaluation of surrogate endpoints in mental-health clinical trialsGeert Molenberghs, Tomasz Burzykowski, Ariel Alonso, et al.Biometrics|February 12, 2016
An information-theoretic approach for the evaluation of surrogate endpoints based on causal inferenceAriel Alonso, Wim Van der Elst, Geert Molenberghs, et al.Biometrical Journal. Biometrische Zeitschrift|February 17, 2015
Statistical evaluation of surrogate endpoints with examples from cancer clinical trialsMarc Buyse, Geert Molenberghs, Xavier Paoletti, et al.Biometrics|September 2, 2004
Prentice's approach and the meta-analytic paradigm: a reflection on the role of statistics in the evaluation of surrogate endpointsAriel Alonso, Geert Molenberghs, Tomasz Burzykowski, et al.Statistics in Medicine|October 13, 2005
A unifying approach for surrogate marker validation based on Prentice's criteriaAriel Alonso, Geert Molenberghs, Helena Geys, et al.Biometrical Journal. Biometrische Zeitschrift|September 20, 2022
Generalized pairwise comparisons for censored data: An overviewVaiva Deltuvaite-Thomas, Johan Verbeeck, Tomasz Burzykowski, et al.Pharmaceutical Statistics|November 4, 2006
Surrogate threshold effect: an alternative measure for meta-analytic surrogate endpoint validationTomasz Burzykowski, Marc BuysePageof 60